Emergent BioSolutions (EBS) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.71 +2.44%
Revenue Growth %: -45.6%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -45.6%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.78, $0.08 better than the analyst estimate of $0.70. Revenue for the quarter came in at $168.1 million versus the consensus estimate of $168.07 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
- Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
